MRK Earnings
Merck & Co. Inc. next reports earnings on October 29, 2026. Track record: 4/4 beats.
Earnings Reported
October 29, 2026
Current Price
$149.52
EPS Estimate
Earnings Per Share
$1.86
-8.6% YoY
Trailing EPS
Last 12 months earnings
$1.26
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
16.3
Margin: 3.6%
Analyst Rating
26 analysts
Analyst Sentiment
Buy26 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-09-30 | $2.09 | $2.49 | +19.3% | Beat |
| 2026-06-30 | -$0.26 | -$0.13 | +49.4% | Beat |
| 2026-03-31 | -$1.47 | -$1.28 | +13.1% | Beat |
| 2025-12-31 | $2.01 | $2.04 | +1.5% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $1.86 | $16.6B | -8.6% |
| Next Qtr(+1q) | $2.14 | $16.5B | +267.1% |
| Current Year(0y) | $2.71 | $67.2B | -69.8% |
| Next Year(+1y) | $9.15 | $69.8B | +237.8% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$1.86
Revenue Estimate
$16.6B
Annual EPS Est.
$2.71
-69.8% YoY
MRK Earnings FAQ
When is MRK's next earnings date?
Merck & Co. Inc. (MRK) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $1.86.
Does MRK usually beat earnings estimates?
Merck & Co. Inc. has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is MRK's trailing EPS?
Merck & Co. Inc.'s trailing twelve-month EPS is $1.26. This is calculated from the last four quarters of reported earnings.
What do analysts think about MRK?
26 Wall Street analysts cover Merck & Co. Inc.. The consensus rating is "Buy" with an average price target of $159.60, implying 6.7% upside from the current price.